Stock listing
NASDAQ:SBBP Strongbridge Biopharma PLC Stock
Follow Strongbridge Biopharma PLC into a list and get an email when it puts out news.
Last close · NASDAQ:SBBP
$2.00 USD
Close on Oct 5, 2021 · No longer trades
- Lowest – highest close
- $1.47 – $10.05 USDSince Oct 16, 2015 · lowest Nov 18, 2019 · highest Oct 16, 2015
Delisted NASDAQ:SBBP no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SBBP
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Strongbridge Biopharma PLC on 6ix
- Decks
- 6 decks · latest May 24, 2021
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (May 2021) | Merger or acquisition | 22 slides | May 24, 2021 |
| Investor Presentation (September 2020) | Investor deck | 42 slides | Sep 8, 2020 |
| Shareholder Meeting (April 2020) | Shareholder meeting | 9 slides | Apr 20, 2020 |
| Investor Presentation (February 2020) | Investor deck | 42 slides | Feb 25, 2020 |
| Investor Presentation (November 2019) | Investor deck | 29 slides | Nov 19, 2019 |
| Q2 2018 Earnings Presentation | Earnings | 33 slides | Aug 8, 2018 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John H. Johnson Other companies: Xeris Biopharma Holdings, Inc. (Independent, Non-executive Board Member · Since at least Oct 5, 2021); Axogen, Inc. (Director · Since at least Jul 19, 2021); Verastem, Inc. (Director · Since at least Apr 23, 2020); Applied Therapeutics Inc (Executive Chairman, Director · Dec 19, 2024 – Dec 19, 2024 · Past); Melinta Therapeutics Inc (Chief Executive Officer, Director · Jun 12, 2018 – Jun 27, 2019 · Past); AVEO Pharmaceuticals Inc (Director · Feb 1, 2018 – Feb 1, 2018 · Past); Cempra Inc (Director · Jan 3, 2017 – Jan 3, 2017 · Past); Ocugen, Inc. (Director · Dec 16, 2016 – Jun 15, 2018 · Past); Portola Pharmaceuticals Inc (Director · Jun 17, 2016 – Jul 2, 2020 · Past); Sucampo Pharmaceuticals Inc (Director · Jun 2, 2016 – Feb 13, 2018 · Past) | Chief Executive Officer, Director · Jan 1, 2018 – Oct 5, 2021 · Past |
| David Gill Other companies: Telix Pharmaceuticals Limited (Chair & Independent Non-Executive Director · Since at least May 11, 2026); Y mAbs Therapeutics (Director · Since at least Sep 20, 2018); Evolus, Inc. Common Stock (Director · Since at least Feb 12, 2018); STRATA Skin Sciences, Inc. (Director · May 30, 2018 – Nov 22, 2019 · Past); Melinta Therapeutics Inc (Director · May 25, 2018 – Jun 11, 2019 · Past); Ocugen, Inc. (Director · Dec 9, 2016 – Jun 15, 2018 · Past); Cempra Inc (Director · Jan 1, 2016 – Jan 3, 2017 · Past); EndoChoice Holdings Inc (President and CFO · Aug 14, 2015 – Nov 22, 2016 · Past) | Director · Sep 3, 2019 – Oct 5, 2021 · Past |
| Matt Pauls Other companies: Palvella Therapeutics, Inc. (Director · Since at least Jun 29, 2026); Pelthos Therapeutics Inc. (Director · Since at least Jul 1, 2025); Soleno Therapeutics, Inc. (Director · Since at least Aug 15, 2023); Savara, Inc. (CHIEF EXECUTIVE OFFICER, Director · Since at least Oct 29, 2015); Egalet Corporation (Director · Jan 31, 2019 – May 20, 2020 · Past) | President & CEO, Director · Jan 1, 2018 – Feb 20, 2019 · Past |
| Garheng Kong Other companies: Xeris Biopharma Holdings, Inc. (Director · Since at least Oct 5, 2021); Labcorp Holdings Inc. (Director · Since at least Feb 4, 2020); Venus Concept Inc (Director · Nov 7, 2019 – Mar 24, 2023 · Past); Alimera Sciences Inc (Director · Jun 19, 2019 – Jan 4, 2023 · Past) | Director · May 15, 2019 – Oct 5, 2021 · Past |
| Marten Steen Other companies: Ultragenyx Pharmaceutical Inc. (Director · Jan 30, 2014 – Jan 30, 2014 · Past) | Director · Jan 1, 2018 – Oct 5, 2021 · Past |
Log in to ask 6ix AI your own questions about Strongbridge Biopharma PLC.